AP NEWS

Global Markets for Blood Plasma Products, 2017-2018 & Forecast to 2023 - ResearchAndMarkets.com

January 24, 2019

DUBLIN--(BUSINESS WIRE)--Jan 24, 2019--The “Global Markets for Blood Plasma Products” report has been added to ResearchAndMarkets.com’s offering.

This research report presents an in-depth analysis of the global blood plasma market by product type, application, end user, and geographic market. In addition, the report provides qualitative information related to the mode of delivery for blood plasma.

The report includes key blood plasma products used in various therapeutic treatments as well as an examination of the supply chain from research to manufacturing. The report also features an in-depth analysis of key companies operating in the global blood plasma market and patents that highlight past, current and projected global technology trends.

The blood plasma market is primarily segmented into five major blood plasma components: immunoglobulin, albumin, hyperimmune globulin, coagulation factor concentrates, and other plasma fractionation products. Immunoglobulins are further segmented into intravenous immunoglobulins, subcutaneous immunoglobulins and normal immunoglobulins such as immunoglobulin A (IgA), immunoglobin D (IgD), immunoglobin E (IgE), immunoglobin G (IgG), and immunoglobin M (ISM).

The global blood plasma market is further segmented by application, which helps in understanding the potency of blood plasma products in several therapeutic treatments. Immunology, oncology, pulmonology, rheumatology, transplant, neurology, hematology and other applications are explained in the report. Products based on these applications are explored in detail and their influence on R&D is examined. In the analysis based on end users, the blood plasma market is segmented as hospitals and clinics, research laboratories, academic institutions and blood transfusion centers.

Profiles of the major players in the industry, including ADMA Biologics Inc., Baxter International Inc., Creat Group, Octapharma AG, Shire Plc and TCS Biosciences Ltd.

Other Prominent Players

Arthrex Inc. Cerus Corp. China Biologic Products Inc. CSL Ltd. General Electric Co. Grifols International Sa Innovative Research Intas Pharmaceuticals Ltd. Kedrion Spa LFB Sa Prime Biologics Pte. Ltd. Sanquin Shanghai Raas

For more information about this report visit https://www.researchandmarkets.com/research/tktvsd/global_markets?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190124005387/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Hematology

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHYSICAL THERAPY

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 01/24/2019 07:39 AM/DISC: 01/24/2019 07:39 AM

http://www.businesswire.com/news/home/20190124005387/en

AP RADIO
Update hourly